|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 抗苗勒激素对ICSI治疗中卵巢反应的预测价值显示文摘目的探讨接受卵胞浆内单精子注射(intracytoplasmic sperm injection,ICSI)治疗患者血清及卵泡液中AMH水平对卵巢反应性的预测价值。方法 53例接受ICSI治疗的患者分别使用促性腺激素释放激素激动剂(GnRH-a,40例)长方案和促性腺激素释放激素拮抗剂(GnRH拮抗剂,13例)联合方案促排卵。接受GnRH-a长方案治疗患者降调节后促性腺激素使用第2天检测血清AMH水平。53例患者卵泡穿刺(oocyte pick-up,OPU)当天检测血清及卵泡液中AMH水平。应用SPSS10.0软件分析血清及卵泡液中AMH水平与卵巢反应的相关性。结果 GnRH-a长方案组和GnRH-拮抗剂联合方案组,OPU当天血清及卵泡液中AMH水平差异无统计学意义。GnRH-a长方案促性腺激素治疗第2天血清AMH水平,两组OPU当天血清及卵泡液中AMH水平与获卵数、成熟卵数成正相关,与患者年龄、促性腺激素使用剂量呈负相关,与受精率没有明显相关性。结论控制性超排卵治疗周期血清及卵泡液中AMH水平能预测ICSI治疗后的卵巢反应性。 | 韩巍巍 Schaffrath M Holze V Pollow K Seufert R 童晓文 | 2011 | 同济大学学报(医学版)2011，32，1： | 3 |
| 2 | Sex steroid levels in serum,myometrium,and fibromyomata in correlation with cytoplasmic receptors and 17-beta-hydroxysteroid dehydrogenase activity in different age groups and phase of the menstrual cycle显示文摘 | Eiletz J Genz T Pollow K | 1980 | Arch Gynecol1980，229，1： | 1 |
| 3 | Conception and pharmacodynamic profile of drospirenone 显示文摘 | Elger W Beier S Pollow K | 2003 | Steroids2003，68，10： | 1 |
| 4 | Role of urokinasetype plasminogen activator (uPA)and plasminogen activator inhibitor type1 (PAI-1)for prognosis in endometrial cancer显示文摘 | Steiner E Pollow K Hasenclever D | 2008 | Gynecol Oncol2008，108，： | 1 |
| 5 | Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer显示文摘 | Steiner E Pollow K Hasenclever D | 2008 | Gynecol Oncol2008，108，3： | 1 |
| 6 | Monitoring of RheologicVariables During Postoperative High-Dose Brachytherapy for UterineCancer显示文摘 | von Tempelhof GF Heilmann L Pollow K et a1 | 2004 | Clin Appl Thrombosis/Hemostasis2004，10，： | 1 |
| 7 | Impact of theological variables in cancer显示文摘 | Von Tempelhoff GF Heilmann L Hommel G Pollow K | 2003 | Semin Thromb Hemost2003，29，5： | 1 |
| 8 | Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 ( PAI-1 ) for prognosis in endometrial cancer 显示文摘 | Steiner E Pollow K Hasenclever D | 2008 | Gynecol 0ncol2008，108，3： | 1 |
| 9 | Urokinase and plasminogen activator inhibitor status in primary ovarian carcinomas and ovarian metastatus compared to benign ovarian tumor as a function of histopathological parameters 显示文摘 | Hoffmann G Pollow K Weikel W | 1999 | Clin Chem Lab Med1999，37，1： | 1 |
| 10 | Fetal hemorheology in normal pregnancy and severe preeclampsia 显示文摘 | Heilmann L Rath W Pollow K | 2005 | Clin Hemorheol Microcirc2005，32，3： | 1 |
| 11 | Hemorheological changes in wamen with severe preeclampsia显示文摘 | Heilmann L Rath W Pollow K | 2004 | Clin Hemorheol Microcirc2004，31，1： | 1 |
| 12 | Hemorheological changes in women with severe preeclampsia 显示文摘 | Heilmann L Rath W Pollow K | 2004 | Clin Hemorheol Microeirc2004，31，1： | 1 |
| 13 | Urokinase and plasminogen activator -inhibitor (PAI-1) status in primary ovarian carcinomas and ovarian metastases compared to benign ovarian tumors as a function o{ histopathological parameters 显示文摘 | HOFFMANN G POLLOW K WEIKEL W | 1999 | Clin Chem Lab1999，37，： | 1 |
| 14 | Hemorheological changes in women with severe preeclampsia显示文摘 | Heilmann L Rath W Pollow K | 2004 | Clin Hemorheol Microcirc2004，31，1： | 1 |
| 15 | Hemorheological changes in wamen with severe preeclampsia显示文摘 | Heilmann L Rath W Pollow K | 2004 | Clin Hemorheol Microcirc2004，31，1： | 1 |
| 16 | Fetal hemorheology in normal pregnancy and severe preeclampsia显示文摘 | Heilmann L Rath W Pollow K | 2005 | Clin Hemorheol Microcirc2005，32，3： | 1 |
| 17 | Hemostatic abnormalities in patients with severe preeclampsia 显示文摘 | Heilmann L Rath W Pollow K | 2007 | Clin Appl Thmmb Hemost2007，13，3： | 1 |
| 18 | Hemostatic abnormalities in patients with severe preeclampsic显示文摘 | Heilmann L Rath WJ Pollow K | 2007 | Clin appl thromb2007，13，3： | 1 |
| 19 | Comparison of the in vitro conversion of estradiol- 17 beta to estrone of normal and neoplastic human breast tissue 显示文摘 | Pollow K Boquoi E Baumann J | 1977 | Mol Cell Endocrinol1977，6，45： | 1 |
| 20 | Fetal hemorheology in normal pregnancy and severe preeclampsia显示文摘 | Heilmann L Rath W Pollow K | 2005 | Clin Hemorheol Microcirc2005，32，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员